InvestorsHub Logo
Followers 9
Posts 766
Boards Moderated 0
Alias Born 09/29/2008

Re: None

Friday, 02/09/2018 3:56:31 PM

Friday, February 09, 2018 3:56:31 PM

Post# of 403092
Please correct me if I'm wrong but this is what I see for Kevetrin down the line. When oral testing of Kevetrin is completed and the FDA approves it, Kevetrin will have more efficacy as it will be able to stay in the cancer cells for a longer period of time and establish P53 to its normal function. This will be done by pill dosage and number of pills per day intake.

Kevetrin should be at the top of blockbuster drugs and be worth triple digit sp. It was determined at the end of phase 1 that kevetrin was non toxic at highest tested dosage levels and highest dosages didn't effect greater efficacy. This was because Kevetrin stayed in the body system for short periods after IV. This is my take and I would appreciate a correction to what I have said if I'm off on my deduction. GO IPIX and the pipeline.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News